Clinical Genetic Testin and Early Surgical Intervention in Patients with Multiple Endocrine Neoplasia Type 1 (MEN 1)

Keyphrases

• Clinical Genetics 100%
• Early Surgery 100%
• Multiple Endocrine Neoplasia Type 1 (MEN1) 100%
• Testin 100%
• Genetic Testing 60%
• Kindred 40%
• Neuroendocrine Tumor 40%
• Genetic Test 40%
• MEN1 Gene 40%
• Tumor 20%
• Disease-related 20%
• Healthy Individuals 20%
• Neoplasia 20%
• Clinical High Risk 20%
• Tumor Suppressor Gene 20%
• Early Detection 20%
• Surgical Intervention 20%
• Pancreatic Polypeptide 20%
• Large Group 20%
• Disease-associated 20%
• Mass Lesion 20%
• Delayed Diagnosis 20%
• Multi-target 20%
• Clinical Symptoms 20%
• Screening Method 20%
• Clinical Signs 20%
• Endocrine Disorders 20%
• Research Laboratories 20%
• Genetic Counseling 20%
• Hyperparathyroidism 20%
• Hypercalcemia 20%
• Germline mutation 20%
• Normocalcemic 20%
• Duodenum 20%
• Malignant Potential 20%
• Mutation Detection 20%
• Parathyroidectomy 20%
• Multifocality 20%
• Molecular Diagnostics Laboratory 20%
• Extended Family 20%
• Cancer Surveillance 20%
• Potentially Malignant Disorders 20%
• Pancreatic Tail 20%
• Families with multiples 20%
• 15-Year-old Male 20%
• Clinical Genetic Testing 20%
• Comprehensive Program 20%
• Direct Genetic 20%
• Neuroendocrine Tumors of the Pancreas 20%
• Clinical Molecular Testing 20%
• Biochemical Screening 20%
• Early Tumor Detection 20%

Medicine and Dentistry

• Clinical Genetics 100%
• Multiple Endocrine Neoplasia Type I 100%
• Methyltestosterone 100%
• Surgery 100%
• Genetic Screening 80%
• Neoplasm 60%
• Neuroendocrine Tumor 60%
• Diseases 60%
• Tumor Suppressor Gene 20%
• Tail 20%
• High Risk Population 20%
• Identified Patient 20%
• Screening 20%
• Target Tissue 20%
• Genetic Counseling 20%
• Hyperparathyroidism 20%
• Cancer Epidemiology 20%
• Hypercalcaemia 20%
• Endocrine Disease 20%
• Germline Mutation 20%
• Molecular Diagnosis 20%
• Duodenum 20%
• Parathyroidectomy 20%
• Pancreas Polypeptide 20%

Biochemistry, Genetics and Molecular Biology

• Genetics 100%
• Genetic Screening 100%
• Methyltestosterone 100%
• MEN1 75%
• Genetic Test 50%
• Normal Human 25%
• Tumor Suppressor Gene 25%
• Target Tissue 25%
• High Risk Population 25%
• Screening 25%
• Hypercalcaemia 25%
• Genetic Counseling 25%
• Germline Mutation 25%
• Duodenum 25%
• Biochemical Screening 25%
• Pancreatic Polypeptide 25%